Cytosar (Cytarabine Ampoules) 100 mg/5ml

CYTOSAR (Cytarabine) 100 mg/5ml ampoules is an antimetabolite chemotherapy medication used for cancer treatment. This sterile injectable form is designed for intravenous administration. Store at room temperature and protect from light.

Strength

100 mg/5ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Pfizer

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cytarabine is primarily used to treat certain types of cancer, including leukemia and lymphoma. It works by interfering with cancer cell growth. This medication may also be used for other conditions as determined by a healthcare provider. Cytarabine is often part of combination chemotherapy regimens.

Side Effects

Cytarabine affects rapidly dividing cells, which can lead to temporary reductions in blood cell counts. Patients may experience fatigue or mild nausea after administration. Hair loss is a possible effect with prolonged use. These effects vary based on individual health and treatment duration.

Precautions & Warnings

Handle Cytarabine ampoules with care to avoid accidental exposure. Use protective gloves and dispose of properly as cytotoxic waste. Keep away from children and pets. Report any signs of infection or unusual bleeding to a healthcare professional immediately.

Avoid Interactions

Cytarabine may interact with other medications that affect the liver, such as certain antifungals or anticonvulsants. Alcohol and grapefruit products should be avoided during treatment. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Cytarabine is used to treat certain cancers, including leukemia and lymphoma, by slowing or stopping cancer cell growth.

Cytarabine is given as an injection into a vein, typically in a clinical setting under medical supervision.

Common effects include fatigue, nausea, and temporary reductions in blood cell counts.

Cytarabine should be stored at room temperature and protected from light until ready for use.

Cytarabine may harm an unborn baby; consult a healthcare provider for guidance if pregnant or planning pregnancy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.